Archana Sud
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Virology 5
- HIV Research and Treatment 4
- Co-authors
- Geoffrey C. FarrellJames G. KenchJason M. HuiKaren BythPriyanka BandaraGeoffrey W. McCaughanJacob GeorgeP Bambery
- Journals
- Nitric Oxide (2 papers)Hepatology (2 papers)Clinical Rheumatology (2 papers)Clinical Infectious Diseases (1 paper)Inflammopharmacology (1 paper)
- Partner nations
- IndiaAustraliaSouth Africa
In The Last Decade
Archana Sud
38 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Hepatology 805
- Epidemiology 1.2k
- Parasitology 161
- Infectious Diseases 303
- Endocrinology, Diabetes and Metabolism 260
Countries citing papers authored by Archana Sud
This map shows the geographic impact of Archana Sud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Archana Sud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Archana Sud more than expected).
Fields of papers citing papers by Archana Sud
This network shows the impact of papers produced by Archana Sud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Archana Sud. The network helps show where Archana Sud may publish in the future.
Co-authors
The 25 scholars most cited alongside Archana Sud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 65 | |
| 2 | 2018 | 12 | |
| 3 | 2017 | 5 | |
| 4 | Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial | 2015 | 2 |
| 5 | 2015 | 137 | |
| 6 | 2010 | 68 | |
| 7 | 2006 | 66 | |
| 8 | 2004 | 139 | |
| 9 | 2003 | 339 | |
| 10 | Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression Hit paper breakdown → | 2003 | 582 |
| 11 | Acute pancreatitis following propoxyfur (Baygon) ingestion. | 2003 | 3 |
| 12 | 2002 | 146 | |
| 13 | 2001 | 11 | |
| 14 | 2001 | 10 | |
| 15 | 2000 | 9 | |
| 16 | 2000 | 19 | |
| 17 | 2000 | 33 | |
| 18 | 1999 | 27 | |
| 19 | 1999 | 7 | |
| 20 | 1998 | 57 |
About Archana Sud
Archana Sud is a scholar working on Medical Terminology, Virology, Hepatology, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 38 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), HIV Research and Treatment (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Hepatology (805 citations), Epidemiology (1.2k citations), Parasitology (161 citations), Infectious Diseases (303 citations) and Endocrinology, Diabetes and Metabolism (260 citations). Archana Sud has collaborated with scholars based in India, Australia and South Africa. Frequent co-authors include Geoffrey C. Farrell, James G. Kench, Jason M. Hui, Karen Byth, Priyanka Bandara, Geoffrey W. McCaughan, Jacob George, P Bambery, Ajay Wanchu and Nancy Malla. Their work appears in journals such as Nitric Oxide, Hepatology, Clinical Rheumatology, Clinical Infectious Diseases and Inflammopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.